В. А. Анисимова

966 total citations
140 papers, 735 citations indexed

About

В. А. Анисимова is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, В. А. Анисимова has authored 140 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Organic Chemistry, 23 papers in Molecular Biology and 13 papers in Pharmacology. Recurrent topics in В. А. Анисимова's work include Synthesis and biological activity (45 papers), Synthesis and Characterization of Heterocyclic Compounds (42 papers) and Synthesis and Reactions of Organic Compounds (20 papers). В. А. Анисимова is often cited by papers focused on Synthesis and biological activity (45 papers), Synthesis and Characterization of Heterocyclic Compounds (42 papers) and Synthesis and Reactions of Organic Compounds (20 papers). В. А. Анисимова collaborates with scholars based in Russia, Belarus and Malaysia. В. А. Анисимова's co-authors include А. А. Спасов, Л. И. Бугаева, D. S. Yakovlev, Т. А. Кузьменко, A. M. Simonov, А. С. Морковник, Nafeeza Mohd Ismail, Л. Н. Диваева, Igor Iezhitsa and Renu Agarwal and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Pure and Applied Chemistry.

In The Last Decade

В. А. Анисимова

128 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
В. А. Анисимова Russia 11 508 207 74 42 40 140 735
Eric A. Voight United States 17 551 1.1× 268 1.3× 63 0.9× 22 0.5× 53 1.3× 42 949
Shawn P. Maddaford Canada 18 563 1.1× 253 1.2× 57 0.8× 59 1.4× 59 1.5× 34 915
David K. Dean United Kingdom 15 442 0.9× 304 1.5× 58 0.8× 39 0.9× 31 0.8× 28 768
Pelin Kelicen Türkiye 11 711 1.4× 131 0.6× 61 0.8× 40 1.0× 14 0.3× 22 875
Hayato Fukuda Japan 18 322 0.6× 213 1.0× 66 0.9× 28 0.7× 63 1.6× 61 848
Umberto Maria Battisti Italy 16 362 0.7× 383 1.9× 98 1.3× 56 1.3× 140 3.5× 68 808
Hilmi Burak Kandilci Türkiye 12 402 0.8× 176 0.9× 59 0.8× 43 1.0× 63 1.6× 24 676
A. Michael Crider United States 17 542 1.1× 378 1.8× 159 2.1× 105 2.5× 155 3.9× 55 1.0k
Ralf Devant Germany 13 285 0.6× 266 1.3× 45 0.6× 76 1.8× 39 1.0× 15 590
Jegadeesan Vaigunda Ragavendran India 13 286 0.6× 164 0.8× 81 1.1× 78 1.9× 93 2.3× 19 562

Countries citing papers authored by В. А. Анисимова

Since Specialization
Citations

This map shows the geographic impact of В. А. Анисимова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. А. Анисимова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. А. Анисимова more than expected).

Fields of papers citing papers by В. А. Анисимова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В. А. Анисимова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. А. Анисимова. The network helps show where В. А. Анисимова may publish in the future.

Co-authorship network of co-authors of В. А. Анисимова

This figure shows the co-authorship network connecting the top 25 collaborators of В. А. Анисимова. A scholar is included among the top collaborators of В. А. Анисимова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В. А. Анисимова. В. А. Анисимова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Спасов, А. А., et al.. (2020). Study of aversive and p38 mapk-inhibitory properties of kappa-agonist with analgesic activity – compound RU-1205. SHILAP Revista de lepidopterología. 6(3). 59–65. 1 indexed citations
2.
Iezhitsa, Igor, et al.. (2019). Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension. European Journal of Pharmacology. 850. 75–87. 11 indexed citations
3.
Yakovlev, D. S., et al.. (2018). ANALYTICAL PROPERTIES OF COMPOUND RU-31. Journal of Volgograd State Medical University. 15(3). 28–32. 6 indexed citations
5.
Спасов, А. А., et al.. (2017). Study of μ- and δ-Opioid Activities in Agents with Various κ-Receptor Selectivity. Bulletin of Experimental Biology and Medicine. 162(5). 632–635. 6 indexed citations
6.
Анисимова, В. А., et al.. (2016). 1-Substituted 2-Benzylaminobenzimidazoles with Phenyl Methoxyls: Synthesis, Computer Prediction, and Pharmacological Activity. Pharmaceutical Chemistry Journal. 49(11). 735–742. 2 indexed citations
7.
Спасов, А. А., et al.. (2016). Antiepileptic Activity of a New Derivative of Benzimidazole RU-1205. Bulletin of Experimental Biology and Medicine. 160(3). 336–339. 2 indexed citations
8.
Спасов, А. А., et al.. (2015). Pharmacokinetic and analgesic properties of the injectable dosage form of a new imidazobenzimidazole derivative RU-1205 with kappa agonist activity. Biomeditsinskaya Khimiya. 61(5). 636–639. 2 indexed citations
9.
Спасов, А. А., et al.. (2013). [Analgesic properties of morpholinoethylimidazobenzimidazole derivative RU-1205].. PubMed. 76(9). 15–8. 2 indexed citations
10.
Спасов, А. А., et al.. (2013). Antioxidant Properties of Pyrrolobenzimidazole Derivative RU-792: Experimental Study. Bulletin of Experimental Biology and Medicine. 155(4). 461–463. 6 indexed citations
11.
Анисимова, В. А., et al.. (2013). Studies of Imidazo[1,2-a]Benzimidazoles 31*. Synthesis of 3-(9H-Imidazo[1,2-a]Benz-Imidazol-3-yl)Acrylic Acids. Chemistry of Heterocyclic Compounds. 49(9). 1285–1288. 1 indexed citations
12.
Спасов, А. А., et al.. (2012). Elucidation of the Mechanisms of Membranotropic Effects of RU-1203 on Ionic Channels of Lymnaea Stagnalis Neurons. Bulletin of Experimental Biology and Medicine. 153(3). 301–304. 1 indexed citations
13.
Анисимова, В. А., et al.. (2011). Research in the field of imidazo[1,2-a]benzimidazole derivatives. XXX. Synthesis and properties of (imidazo[1,2-a]benzimidazolyl-2)acetic acids. Russian Journal of Bioorganic Chemistry. 37(6). 758–764. 2 indexed citations
14.
Анисимова, В. А., et al.. (2010). Synthesis and pharmacological activity of 9-R-2-halogenophenylimidazo[1,2-a]benzimidazoles. Pharmaceutical Chemistry Journal. 44(7). 345–351. 12 indexed citations
16.
Анисимова, В. А., et al.. (2003). Mechanisms Underlying Combined Action of Clonidine and Local Anesthetics. Bulletin of Experimental Biology and Medicine. 136(1). 53–55. 1 indexed citations
17.
Анисимова, В. А., et al.. (2003). [Genetic typing of Mycobacterium tuberculosis strains by spoligotyping and genome fingerprinting techniques].. PubMed. 30–5. 5 indexed citations
18.
Анисимова, В. А., et al.. (2002). Synthesis and Pharmacological Activity of 3-Aroyl- and 3-Hetaroylimidazo[1,2-a]benzimidazoles. Pharmaceutical Chemistry Journal. 36(12). 637–642. 9 indexed citations
19.
Анисимова, В. А., et al.. (1986). Studies of imidazo[1,2-a]benzimidazole derivatives. 21. Synthesis of haloketones in the imidazo[1,2-a] benzimidazole series. Chemistry of Heterocyclic Compounds. 22(3). 275–282. 1 indexed citations
20.
Анисимова, В. А., et al.. (1980). Chloral as a formylating agent for some bridge heterosystems. Chemistry of Heterocyclic Compounds. 16(4). 409–417. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026